Concepedia

Daijun Xing

DX

Statistics

Publications

1

Citations

14

H-Index

1

Active since

2023

Affiliations

Shandong First Medical University(Current)

Daijun Xing is an author at Shandong First Medical University specializing in cancer therapeutics, lung cancer, and tumor biology.

Top concepts

Publications per year

2023–2023

1

Publications

1

Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway.

Guodong Huang, Xinning Liu, Ting Jiang et al. · PubMed · 2023 · 14 citations · Full text

, , +15

1–1 of 1